Search

everythinglearnresearchcommunity

for

Search:↓

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Hair characteristics might be early signs of Type 2 Diabetes and could help with early prevention.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

The water extract of Bituminaria bituminosa, high in phenolic compounds, shows strong antioxidant and enzyme inhibitory potential.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Men with Type 2 Diabetes have lower DHT levels, which may affect fertility and lipid profiles.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

The effects of estrogen on human scalp hair growth are unclear and need more research.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Baricitinib is effective and safe for treating severe alopecia areata.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Rats had lasting erectile problems after stopping a certain medication.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

New compounds may soon be tested to treat excessive hair growth in women.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Fat stem cells from diabetic mice can still help heal wounds.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

SLE patients experience two patterns of non-inflammatory symptoms: intermittent and persistent.